New York, USA, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Warm Autoimmune Hemolytic Anemia Market is Predicted to Exhibit Remarkable Growth by 2032, Analyzes DelveInsight | Leading...
Benzinga - by Benzinga Insights, Benzinga Staff Writer. Johnson & Johnson's (NYSE:JNJ) short percent of float has fallen 58.36% since its last report. The company recently...
Eli Lilly & Co (NYSE:LLY). experienced a decrease in share value for the second consecutive day, with a 3.42% drop on Thursday, closing at $550.13. This downturn is part of a...
On Tuesday, IDEXX Laboratories Inc. (NASDAQ:IDXX) shares closed at $457.38, marking a 1.58% increase, breaking the company's two-day losing streak. This rise came in contrast to...
By Ludwig Burger and Paul Arnold FRANKFURT (Reuters) - Sandoz plans to launch at least five additional biologic drugs, its CEO Richard Saynor said, as the generics drugs business...
Benzinga - by Priya Nigam, Benzinga Staff Writer. On CNBC’s "Mad Money Lightning Round," Jim Cramer said yes to The St. Joe Company (NYSE: JOE). "I’ve liked St. Joe...
In a recent lawsuit, Johnson & Johnson (NYSE: JNJ) and Procter & Gamble Co (NYSE: PG) are facing allegations of misleading consumers regarding decongestant cold medicines...
Kenvur buyers return to jnj? Double discount/double dip...? LOL?
0
Niceee movement
0
Interest rates?
0
FDA approved finally. Few minutes ago!!!!
0
What?
0
Invested in J&J a couples years back and have closely followed the pharmaceutical industry. Found a company by the name of SpectrumX which has an IPO set for November. SpectrumX are leaders in patented shielded HOCL formulations that have numerous applications in medical/pharma fields. They have also undergone 2 clinical trails for Covid-19 treatment (apparently not factored into the company valuation.) To me this company seems to be on track for high growth after the IPO, however I may be getting lost in the hype. Would love to hear people's thoughts on the stock as I am keen to invest early.